News for Healthier Living

Survivors of High-Risk Neuroblastoma Face Substantial Late Effects of Modern Therapies

Within the last two decades, multiple stem cell transplants and immunotherapy were added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood cancer.

October 20, 2025


October 29 2025

October 28 2025

October 27 2025

October 26 2025

October 25 2025

October 24 2025

October 23 2025

October 22 2025

October 21 2025

October 20 2025

October 19 2025

October 18 2025

October 17 2025

October 16 2025